Table 1 Demographic information and etiology of Inflammatory Bowel Disease patients and controls

Gender (%female)

50,86

53,33

53,15

Age (yr)

 Mean

38,4+/−12,2

44,9+/−12,9

40,0+/−12,94

 Range

16–77

21–69

19–61

 ND

16,5 %

8 %

Drugs (%)

 Azathioprine

43,35

15,20

-

 Budenoside

3,47

4,80

-

 Infliximab

15,60

2,90

-

 Mesasalazine

57,23

63,80

-

 Metronidazol

4,62

2,90

-

 Prednisolone

8,67

11,40

-

Disease Location (%)

 Rectum (E1)

-

41,90

-

 Left colon (E2)

-

17,10

-

 Colon (E3, L2)

12,70

31,40

-

 Ileum (L1)

42,2

-

-

 Ileocolon (L3)

30,60

-

-

 Upper digestive tract (L4)

2,90

-

-

 ND

11,60

9,50

-

Active Disease (%)

16,18

14,28

-